MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

lifespin

Lifespin launches commercial access to its metabolic profiler software and database for pharma and biobank services

, 28 September 2022/in E-News /by panglobal

Lifespin, based in Regensburg, Germany, with offices in Boston, Massachusetts, has launched a new commercial service that, for the first time, will provide the pharma­ceutical and biobanking industry with access to its proprietary metabolic database, as well as its advanced interpretive software to assist in various phases of drug research, development, and manufacturing.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/lifespin.png 510 1308 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 12:26:122022-09-28 12:26:12Lifespin launches commercial access to its metabolic profiler software and database for pharma and biobank services
Absolute Antibody

Absolute Antibody expands production to support demand for its recombinant antibodies

, 28 September 2022/in E-News /by panglobal

Absolute Antibody, an industry-leading provider of recombinant antibody products and services, is expanding its manufacturing facility in northeast England. The increased laboratory space includes a major investment in new automation for Next Generation Sequencing (NGS), expression and purification (HPLC) to enhance recombinant antibody production workflows. The additional space and equipment will enable Absolute Antibody to […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/Absolute_Antibody.png 426 998 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 12:23:062022-09-28 12:23:06Absolute Antibody expands production to support demand for its recombinant antibodies
accelerate arc

BD, Accelerate Diagnostics announce global commercial collaboration

, 28 September 2022/in E-News /by panglobal

BD (Becton, Dickinson and Company) and Accelerate Diagnostics, an innovator of rapid in-vitro diagnostics in microbiology, announced a worldwide commercial collaboration agreement where BD will offer Accelerate’s rapid testing solution for antibiotic resistance and susceptibility. The test offers results in hours, versus one to two days with some traditional laboratory methods.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/accelerate_arc.png 950 898 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 12:20:282022-09-28 12:20:28BD, Accelerate Diagnostics announce global commercial collaboration
ProBioGen

ProBioGen and City of Hope ink license to use AGE1.CR.pIX vaccine manufacturing platform for cytomegalovirus vaccine

, 28 September 2022/in E-News /by panglobal

ProBioGen and City of Hope, one of the largest cancer research and treatment organizations in the United States, have signed an non-exclusive commercial license agreement that will allow City of Hope to manufacture its innovative synthetic MVA-based CMV vaccine using ProBioGen’s cell-based and scalable viral manufacturing platform AGE1.CR.pIX.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/ProBioGen.png 294 820 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 10:11:492022-09-28 10:12:09ProBioGen and City of Hope ink license to use AGE1.CR.pIX vaccine manufacturing platform for cytomegalovirus vaccine
Dr Louise Modis 1

Mogrify and Astellas initiate research collaboration on in vivo regenerative medicine approaches to address sensorineural hearing loss

, 28 September 2022/in E-News /by panglobal

Biopharmaceutical company Mogrify and Astellas Pharma have initiated a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/Dr-Louise-Modis-1.jpg 1378 1672 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 10:05:402024-08-21 13:56:03Mogrify and Astellas initiate research collaboration on in vivo regenerative medicine approaches to address sensorineural hearing loss
Indica Labs

Indica Labs to collaborate with iCAIRD for development of an AI-based algorithm for automated reporting of lymph node status in colon cancer

, 28 September 2022/in E-News /by panglobal

Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), will collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases. The primary aim of the research project […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/Indica-Labs.png 2250 4000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 09:57:182022-09-28 10:04:03Indica Labs to collaborate with iCAIRD for development of an AI-based algorithm for automated reporting of lymph node status in colon cancer
PorvairPR599 image

Medical device components that inhibit bacterial growth

, 26 September 2022/in E-News, Product News /by panglobal

Vyon® porous plastics from Porvair Sciences are the perfect material for filtration applications in the healthcare and medical devicemarket

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/PorvairPR599-image.jpg 685 476 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-26 06:39:242022-09-26 06:47:26Medical device components that inhibit bacterial growth
image002

PhoreMost enters multi-project drug target discovery collaboration with Roche

, 26 September 2022/in E-News /by panglobal

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/image002.jpg 155 128 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-26 06:30:462022-09-26 06:32:16PhoreMost enters multi-project drug target discovery collaboration with Roche
1905 Diasys 0212 EBV 3

Press release: DiaSys introduces dedicated respons® and BioMajesty® JCA-BM6010/C kits for Procalcitonin FS

, 22 September 2022/in E-News /by panglobal

After two years of successful marketing of Procalcitonin FS, dedicated kits are now available for the DiaSys respons® systems and BioMajesty® JCA-BM6010/C. Procalcitonin FS offers a reliable alternative, when time matters in sepsis management.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/1905_Diasys_0212_EBV-3.jpg 400 600 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-22 17:25:082022-09-22 17:26:26Press release: DiaSys introduces dedicated respons® and BioMajesty® JCA-BM6010/C kits for Procalcitonin FS
MiRXES uses the ASSIST PLUS pipetting robot from INTEGRA to load samples onto plates in preparation for microRNA assays.

Press release: INTEGRA’s automated pipetting solutions improve accuracy and reproducibility for microRNA-based diagnostics

, 16 September 2022/in E-News /by panglobal

MiRXES, a biotechnology company based in Singapore, is relying on a range of INTEGRA pipetting systems to increase the speed and precision of its RT-qPCR workflows. Adam Chiow, Senior Research Officer at MiRXES, explained: “We are using a proprietary RT-qPCR technology platform – ID3EAL™ – to identify new microRNA biomarkers and develop diagnostic kits for […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/MiRXES-uses-the-ASSIST-PLUS-pipetting-robot-from-INTEGRA-to-load-samples-onto-plates-in-preparation-for-microRNA-assays..jpg 622 456 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-16 13:58:242022-09-16 14:02:36Press release: INTEGRA’s automated pipetting solutions improve accuracy and reproducibility for microRNA-based diagnostics
Page 55 of 231«‹5354555657›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription